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ABSTRACT 
Effect of Activators on Promoter Clearance by RNA Polymerase II 
Jason Dwain Grier. (Dr. David 0. Peterson) 
University Undergraduate Research Fellow, 1998-1999 
Texas ARM University 
Depa&ament of B&ochemistry and Biophysics 
Euka&yotic transcription is a complex and highly regulated process. The adenovirus 
major late (AdML) pro&noter, a model promoter for transcription by RNA polymerasc II 
(pol II), contains a bmding site for the transcriptional activator upstrea&n stimulatory factor 
(USF), P&evious experiments showed that deletions in the USF site in AdML promoter 
decrease the stability of ATP-activated transcription complexes. As a result we wanted to 
look at the effect USF had on the rate of promoter clearance by pol II in vitro. 
To develop an assay for promoter clearance, special DNA templates werc constructed 
such that a G at position +11 is the only G incorporated into the growing RNA in thc first 
36 nucleotides of RNA synthesis. Our assay for promoter clearance is designed to measure 
whether pol II has passed postition +11 at a given time, t, and depends on the ability of thc 
chain terminating nucleotide 3'-0-methyl GTP (added at t) to quantitatively stop 
transcription if it is incorporated into the RNA a&. +11. 
Controls for the promoter clearance assay are in progress. So far controls have shov n 
the presence of promoter specific transcripts from our templates that are distinguishable 
from the background. In addition, 3'-0-methyl GTP at high concentrations has been 
shown to tenmnate transcription almost completely. However, i&. is still not quite clear il'it 
is efficient enough for the promoter clearance assay. 
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INTRODUCTION 
Mammals contain tens of thousands of genes encoded within their DNA. Converting the 
information stored within these genes to a final product, protein or RNA, mvolves a series 
of processes. Transcription, the process responsible for converting a gene's DNA 
sequence into an intermediary, RNA, consists of many highly regulated steps. 
Understanding the regulation of these steps has thc potential to impact the study of many 
biological pathways, i. e. apoptosis, which when defecttvc in these regulatory steps may 
result m a disease or disorder such as cancer. In addition, this understanding may lead to 
developing cures or better treatments for these diseases. 
RNA polymerascs are responsible for the enzymatic activity of synthesizing RNA 
chains. Prokaryotes possess one major RNA polytnerase while cukaryotes possess three 
separate RNA polymerases characterized by their sensitivity to fungal toxin u-amanitin. 
RNA polymerase I (pol I), insensitive to u-arnanitin, transcribcs class I genes encoding 
ribosomal RNA. RNA polymerasc II (pol II), sensitive to I ltg/ml of u-amanitin, 
transcribes class Il genes encoding mRNA and small nuclear RNA (Ul-U5). RNA 
polymerase III (pol Ill), sensitive to an u-amanitin concentration of 50 kg/ml, transcribes 
class III genes encoding transfer RNAs, 5S ribosomal RNA and U6 small nuclear RNA. 
The eukaryottc RNA polymerases lack the ability to transcribe genes accurately and 
effictcntly; thus they require additional factors to recognize thetr respective promoters. In 
the following work the studies involve pol II, thus the subsequent descriptions relate to 
transcription involving pol II. 
Characteristics of class II promoters 
A class II promoter contains a set of DNA sequences involved in basal levels of 
transcription while regulators modify these levels in a positive (activator) or negative 
(repressor) fashion. The promoter consists of a combination of sequences including core 
promoter elements, proximal promoter elements, and distal enhancer elements. 
Core promoter elements are necessary for accurate and site-specific transcription 
initiation by pol II and associated transcription factors. Two of the best-known core 
promoter elements arc the TATA box and initiator (lnr) (Kollmar and Farnham, 1993). All 
known pol II promoters contain at least one of the two elements, which function 
independently or in conjunction. The TATA box is an AT-rich region located about 30 
base pairs (bp) upstream of the transcription start site (+1) while the Inr is located at the 
start site. Promoters lacking TATA boxes contain GC-rich regions 5' to the +I site and 
usually initiator elements (Carcamo et al. , 1991; Conaway and Conaway, 1993; Smale and 
Baltimore, 1989). 
In addition to core promoter elements, DNA binding domains for regulators exist. 
These domains may bc adjacent to the promoter, upstream or downstream of the promoter, 
or thousands of bp away. In addition, many act independent of orientation. The regulatory 
factors bind in a trans fashion and, in addition to DNA binding domains, contain activation 
or repression domains. Activators have been shown to aid in transcription complex 
assembly, For example, GAL4-AH promotes closed transcription complex formation at 
the adenovirus E4 promoter (Wang ct al. , 1992b). Additional functions for activators are: 
help in recruitment of transcription factors, stabtlize protein-protein or protein-DNA 
interactions, and stabilization of transcription complexes. However, little is known about 
how activators affect events beyond complex assembly. Activator GAL4-VP16 was 
shown to stimulate elongation processivity (Yankulov et al. , 1994). 
Transcription complex assembly 
Transcription consists of major phases, which themselves consists of many steps, all of 
which may be regulated. Thc first major phase, initiation, begins with the first step 
formation of a closed transcription complex on the promoter. Two models exist for the 
formation of a transcription complex: ordered stepwise assembly and pol Il holoenzyme 
assembly. 
Pol II requires additional factors (Fig. 1), termed general transcription factors (GTFs), 
to ensure accurate initiation of transcription (Roeder, 1996). In a stepwise assembly model 
the GTFs and pol ll assemble on the promoter DNA through a series of steps. The 
sequence of GTF assembly on the adenovirus major late (AdML) promoter in vitro was 
determined via gel mobility shift assays (Buratowski et. al. , 1989). The series of steps 
begins with TFIID and TFIIA forming a complex at the TATA box, followed by TFIIB. 
The DNA-binding subunit of TFIID, the TATA — binding protein (TBP), forms a stable 
complex (Hoopes et al. , 1992) distotring the DNA sequences upstream and downstream of 
the TATA box into closer proximity (Burley and Roeder, 1996; Nikolov and Burley, 1997; 
Rocder, 1996). TFIIB, through interaction with TBP, contacts the DNA sequences 
upstream and downstream of the TATA box (Nikolov et al. 1995). Next, RNA pol II, in 
association with TI'IIF, can becotne part of thc complex through direct interactions with 
TFIIB. Then recruitment of TFIIE, which interacts with pol ll, occurs. Finally, TFIIE 
recruits and makes direct contacts with TFIIH completing the closed complex. 
The alternative model, pol II holoenzyme assembly, challenges the stepwise assembly. 
A pol II holoenzyme in solution has pol ll, TFIIE, TFIIF, and TFIIH preassembled 
together. A number of complexes purified by conventional chromatography or by antibody 
affinity chromatography using an anti-TFIIF antibody lacked stochiometric amounts of 
TFIIB, TFIID, TFIIE, and/ or TI'IIH (Koleske and Young, 1994; Cho et al. , 1997; 
Maldonado et al. , 1996; Kim et al. , 1994). Pol ll complexes lackmg only 'lTIIA were 
isolated using protein affmtty chromatography or an antibody to the TFIIH subunit 
cdk7(Pan et al. , 1997; Ossipow ct al. , 1995). All of these complexes are known as pol II 
holoenzymc complexes and are capable of basal transcription with the addition of their 
respective missmg GTFs. In some cases thc holoenzyme complexes are capable in vitro of 
activated transcription (Kolcske and Young, 1994; Maldonado et al. , 1996; Pan et al. , 
1997). 
RNA polymerase II general 
transcription factors 
TFIIA 37kD 
19kD Activation 
13kD 
TFIIB 
TFIID TEP 
TAFII250 
TAFII 150 
TAFII135 
TAFII95 
TAFII80 
TAF II55 
TAFII31 
TAFII28 
TAFII20 
38kD 
250kD 
150kD 
135kD 
95kD 
80kD 
55kD 
31kD 
28kD 
20kD 
binds TATA box 
35kD recruits RNAPII; start site selection 
TFIIE 56kD ~ 
modulates TFIIH activity 
TFIIF RAP74 
RAP30 
58kD 
26kD 
stimulates elongation 
a homology 
TFIIH ERCC3 
ERCCZ 
p62 
hSSL1 
cdk7 
cyclin II 
p34 
MAT-1 
89kD 
80kD 
GZkD 
44kD 
40kD 
37kD 
34kD 
32kD 
3'-5' helicase 
5'-3' helicase 
excision repair 
excision repair 
CTD kine se 
cdk7 partner 
kinase assembly factor 
Fig. 1. The table above lists the RNA polymerase II general transcription factors, their 
size, and known functions, 
RNA polymerase II 
Transcription in bacteria involves a single RNA polymerase composed of three types of 
subunits P', P, and tz. One or more additional proteins (o subunits) confer selective 
promoter recognition and regulatory functions upon the core prokaryotic polymerase 
(Helmann and Chamberlin, 1988; McClure, 1985). Thrcc types of RNA polymerases exist 
within eukaryotes. These cukaryotic polymerases consist of 8 to 14 polypeptidcs. In 
addition, thc polytnerases requtre many additional factors to confer selective promoter 
recognition and regulatory functions (Geiduschek and Tocchini-Valentini, 1988; Mitchell 
and Tjian, 1989; Ptashne, 1988; Struhl, 1989). This suggests that eukaryotes need more 
intricate transcriptional control. 
Transcriptionally active pol II has been purified from many different eukaryotes, such as 
yeast (Scntenac, 1985) and humans (Freund and McGuire, 1986), through column 
chromatography or immunological methods (Kim and Dahmus, 1988; Ossipow et al. , 
1995). Throughout the eukaryotes three features of pol II are conserved. I'irst, pol II 
consists of 8 to 12 subunits. Second, two large subunits of about 220 kDa and 140 kDa are 
present consistently. In yeast these two subunits are functional homologues to the large 
prokaryotic subunits, P' and P (Allison ct al. , 1985; Sweetser et al. , 1987). Third, three 
pol II subunits ranging in size from 14 kDa to 28 kDa are also associated with pol I and III. 
A difference between the largest prokaryotic subunit and largest pol II subunit is the 
presence of a carboxy terminal domain (CTD) in the cukaryotic subunit. The highly 
conserved CTD consists of many heptapeptidc repeats of the consensus sequence Tyr-Ser- 
Pro-Thr-Ser-Pro-Ser (Allison et al. , 1985; Bird and Riddle, 1989; Corden et al, 1985). 
Pol II purified from different eukaryotic species vary in thc length of the repeats. F' or 
example, yeast 26 to 27 repeats (Allison ct al. , 1985) while humans have 52 repeats 
(Cordcn et al. , 1985; Young, 1991), Many different electrophoretic forms have bccn 
isolated based on the degree of phosphorylation of thc CTD (Allison ct al. , 1985; Corden ct 
al. , 1985). 
During the formation of a closed transcription complex at the promoter, only the 
nonphosphorylated form of pol II can bind (Laybourn and Dahmus, 1990). In the shift 
from transcriptional initiation to elongation the CTD becomes hyperphosphorylated 
indicating a potential function of phosphorylalion in promoter clearance and elongation 
(Parada and Roeder, 1996), Deletion mutations of all or most of the CTD in yeast and 
Drr&sophila cells are lethal (Allison et al. , 1988; Pinto et al. , 1994). In vitro transcription 
experiments using human HeLa nuclear extracts indicate in some promoters CTD is needed 
for efficient promoter-dependent transcription (Buratowski et al. , 1989; Thompson et al. , 
1989). 
TIi'IID 
TFIID consists of a TBP subunit and nine TBP associated factors (TAFs). TI'11D 
activity was first discovered in human nuclear extracts (Matsui et al. , 1980), but difficulties 
existed in purifying and studying the factor. On the other hand, a polypeptide of 27 kDa 
isolated from transcriptionally active yeast extracts possessed the same activity as TFIID 
(Cavallini et al. , 1989; Hahn ct al. , 1989b; Hernandez, 1993; Schmidt et al. , 1989). As a 
result, a cDNA encoding the yeast TBP (Cavallini ct al. , 1989; Hahn et al. , 1989b; 
Horikoshi et al. , 1989; Schmidt et al. , 1989) led to the cloning of TBP in other eukatyotes 
such as humans (Hoffman et al. , 1990; Kao et al, 1990; Peterson et al. , 1990). These 
TBPs facilitated transcription like rnamtnalian TFIID but did not respond to transcriptional 
acti vators (Hoey et al. , 1990; Peterson et al. , 1990; Pugh and Tjian, 1990; Smale et al. , 
1990). It was deduced from TFIID's molecular weight of -750 kDa (Conaway et al. , 
1990; Nakajima ct al. , 1988) that other factors existed that functioned in transcriptional 
activation. TAFs (Dynlacht et al. , 1991; Tanese et al. 1991), also known as coactivators 
(Peterson et al. , 1990; Pugh and Tjian, 1990), have a possible role in transcriptional 
activation. 
The TBP subunit vanes in size in different species, 22 kDa to 38 kDa. It consists of 
two domains, a carboxy-terminal TATA-bmding domain and an arruno terminal domain. 
While the TATA-binding domain is highly conserved, the amino terminal domain shows 
little conservation between species. The function of the amino terminal domain is not clem, 
but the TATA-binding domain has been shown to function in specific transcription 
imtiation and TFIID complex formation (Hoey et al. , 1990; Zhou, 1993). 
The TATA- binding domain has the shape ol' a saddle (Chasman et al. , 1993; Nikolov et 
al. , 1995) where the concave underside binds DNA and the convex outer surface serves as 
a binding sttc of other GTFs (Nikolov et al. . 1997). The carboxy terminal domain binds 
TATA elements with high sflinity (Hahn et al. , 1989a). It interacts with the minor groove 
(Starr and Hawley, 1991) leading to partial unwinding and bending of the DNA (Kim et 
al. , 1993). The bending of the DNA may help in bringing proxtmal DNA elements to the 
start site or assist in the interactions of GTFs with activators and pol II. 
TFIID has at least twelve TAFs ranging in size from 15 to 250 kDa. Most of the human 
pol II TAFs have been cloned and are highly conserved. In vitro TAFs are required for 
promoter recognition and activator-dependent transcriptional stimulation in both humans 
and Drosophila systems, however the role in vivo is not clear (Nakatani et al. , 1990; 
Orphanides et al. , 1996). 
TFII A 
TFIIA has been isolated from yeast (Ranish et al. , 1992), humans (De Jung et al. , 1993; 
Ma et al. , 1993; Ozer et al. , 1994), and Drosophila (Yokomori et al. , 1994). Human and 
Drosophila TFIIA consists ol' three subunits (Cortes, 1992): cr (37kDa), f3 (19kDa), and y 
(13kDa) while yeast consists of two (Ranish et al. , 1992). Thc subunits of yeast and 
humans sharc some homology. 
The need for TFIIA varies in difierent reconstituted transcription systems. TFIIA 
stimulates transcription reactions involving TFIID (Ozer et al. , 1994; Sun et al. , 1994; 
Yokomori et al. , 1994), posstbly by neutralizing the activity of some repressors, but does 
not stitnulate reactions involving recombinant TBP (Cottes, 1992). Howcvcr, transcription 
using TFIID immunopurified to homogeneity and homogenous preparations of thc other 
GTFs are stimulated by recombinant TFIIA (Ozer et al. , 1994; Sun et al. , 1994). This 
indicates TFIIA has a role in the initiation of basal transcription. TFIIA binds both TBP 
(Cortes, 1992; Ranish and Hahn, 1991) and TBP-DNA complexes (Buratowski et al. , 
1989; Cortes, 1992) increasing TBP affinity for the TATA element (Imbalzano et al. , 1994) 
and enhancing its ability to compete with other proteins bound at the promoter. Besides 
neutralizing repressive activity TFIIA also enhances activation by some activators 
(Yokomori et al. , 1994; Ozer et al. , 1994). Thc P and y subunits arc necessary for 
antirepresston, while all three subunits are responsible for activation (Ma et al. , 1996). 
TFIIB 
TFIIB probably aids in linking promoter-bound TFIID to pol II/TFIIF complexes, in 
addition to specifying the start site of transcription. TFIIB isolated from humans consists 
of a single polypeptide of -35 kDa (Ha et al. , 1991) and possesses homology to TFIIB 
found in yeast (Pinto et al. , 1992) and Drosophila (Wampler and Kadonaga, 1992). The 
polypeptide consists of amino- and carboxy-terminal domains (Barberis et al. , 1993; Malik 
et al. , 1993). The amino-termmal domain contains a zinc-binding domain (Bagby et al. , 
1995) that may stabilize melting of the promoter by binding near the transcription start site 
(Orphanides ct al. , 1996). Support for this idea comes from experiments involving 
mutations next to the ztnc-binding domain that alter start site selection (Pinto et a]. , 1994). 
TFIIB possesses three binding sites for TFIIF (Ha et al. , 1993), pol II (Fang and 
Burton et al. , 1996; Ha et al. , 1993), and the TFIID-DNA complex (Buratowski et al. , 
1989; Maldonado et al. , 1990). Once TFIID has bound the promoter, TFIIB binds the 
TFIID-promoter complex forming a ternary complex increasing stability (Orphanides et al. , 
1996). This ternary complex is then capable of binding the pol llffFIIF complex. 
The core of TFIIB consists of a two domain ct-helical polypeptide believed to interact 
with the carboxy-terminal domain of TBP and the phosphoribose backbone of DNA 
upstream and downstream of the TBP-distorted TATA clement (Nikolov and Burley, 
1997). As a result TFIIB may be responsible for determining the correct polarity of the 
TATA element thus aiding in forming an energetically favorable complex. 
TFIIF. 
TFIIE is a heterotetramer composed of two types of subunits (Inostroza et al. , 1991; 
Ohkuma et al. , 1990), tx (56 kDa) and P (34 kDa). The ct subunit has an acidic carboxy- 
terminus while the P subunit has a basic carboxy-terminus distinguishing the subunits as 
acidic and basic respectively (Peterson et al. ; 1991). Also, the tr subunit has a possible 
zinc-binding domain responsible for stabilizing the melted promoter (Pctcrson et al. , 1991). 
The P subunit contacts the DNA at positions — 2 and — 14 of thc promoter to aid in 
stabilizing the melted region (Robett et al, 1996). 
TFIIE may enter thc complex assembly after TFIID, TFIIA, TFIIB, TFIIF, and pol II or 
at the same tiine as the pol II/TFIIF complex since TFIIE has an high affinii. y for pol 11 
(Orphanides et al, 1996). TFIIE recruits TFIIH to complete a transcription complex ready 
to initiate transcription (Flores et al. , 1990). In addition, TFIIE stimulates transcription 
from supercoiled templates, which may be required during promoter melting (Goodrich and 
Tjian, 1994; Timmers, 1994). 
rrHF 
TFIIF is a heterodimer with two subunits (Flores et al. , 1988; Flores et al. , 1990), 
RAP30 (30 kDa) and RAP74 (74 kDa). It forms a stable complex with pol II allowing the 
pol II/TFIIF coinplex to enter the transcription complex. Crosslinking studies show that 
RAP30 and RAP74 bind ai positions — 5, -15, and -19 of the promoter indicating a location 
between the TATA clement and transcription start site (Robert et al. , 1996). 
Besides forming a complex with pol II, TFIIF prevents and reverses bindmg at 
nonpromoter sites in a manner similar to cr factors in bacteria (Conaway and Conaway, 
1990; Killeen and Grcenblatt, 1992). Not surprisingly, TFIIF has two regions with 
sequence similarity to Lscherichia coli o factors (Garrett et al. , 1992; Sopta et al, 1989). 
In addition, RAP30 has been shown to contain a cryptic DNA-binding domain at its 
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carboxy-terminus similar to E. coli tr (McCracken and Greenblatt, 1991). RAP30 binds 
pol II (McCracken and Greenblatt, 1991), TFIIB (Ha et al, , 1993), and DNA (Tan et al. , 
1994). Via the RAP30-DNA interaction the closed transcription complex may be stabilized 
(Orphanides et al. , 1996). 
RAP30 needs the assistance of RAP74 to assist in some TFIIF functions. RAP74 is 
needed to remove pol II already bound to DNA nonspecifically (Conaway and Conaway, 
1990; Killeen and Greenblatt. , 1992). An additional TFIIF function, particularly of 
RAP74, includes increasing pol II transcription by stably associating with pol II and 
increasing the rate of elongation (Bengal et al. , 1991; Chang et al. , 1993; Kephart et al. , 
1994) . RAP74 may also help in start site selection through its interaction with TFIIB 
(Fang and Burton, 1996). 
The structure of TFIIF may undergo conformational changes during thc phases of 
initiation and elongation. In vivo RAP74 is highly phosphorylated, but in the absence of 
phosphorylation, TFIIF's activity in initiation and elongation are greatly reduced (Kitajma 
et al, 1994), suggesting that phosphorylation may play a role in the regulation of TFIIF 
activity (Dikstein et al. , 1996). 
TIiIIH 
TFIIH consists of nine subuntts ranging in size from 39 kDa to 89 kDa. It was first 
shown to be required in transcription in a system derived from rat liver (Conaway and 
Conaway, 1989), but subsequently it has been shown to be required in yeast and human 
systems. TFIIH possesses many catalytic activities such as DNA-dependent (d)ATPase 
(Conaway and Conaway, 1989; Roy et al. , 1994b), (d)ATP-dependent DNA helicase 
(Schaeffer et al. , 1993), and a scrine/threoninc kinase that can phosphorylate the CTD of 
pol ll (Feaver et al. , 1991; Lu et al. , 1992). TFIIE affects the ATPase, DNA helicase, and 
kinase activities (Drapkin et al. , 1994; Lu et al. , 1992). TFIIE and TFIIH have a high 
binding affintty for each other resulting in a close association throughout the transcription 
process. 
The ATPase/DNA helicase and kinase activities are probably tnvolved in the ATP 
dependent events required during the transition from the closed complex through 
productive elongation. The ATPase/DNA helicase activity requires the hydrolysis of the j)- 
y phosphoanhydridc bond of ATP. A cyclin-dependent kinase (Cdk) MO15/Cdk7 of 
TFIIH (Roy et al. , 1994a; Serizawa et al. , 1995; Shiekhatter et al. , 1995) has been shown 
to have dual functions: CTD-kinase and catalytic subunit of Cdk-activating kinase (CAK). 
CAK is responsible for the phosphorylation and activation of many proteins important to 
the cell-cycle progression (Shiekhatter ct al. , 1995). In addition, the entire CAK complex 
is part of TFIIH (Serizawa et al. , 1995; Shiekhatter et al. , 1995). TFIIH's kinase activity 
may be responsible for release of pol II from the transcription complex by phosphorylation 
of CTD or indirectly regulating pol II by phosphorylating another kinasc that 
phosphorylates CTD. CTD phosphorylation, which could serve as an indicator for 
promoter clearance, may allow disassociation of pol II and association of factors for 
elongation (Svejstrup et al. , 1996). 
TFIIH has been shown to be necessary during transcriptional elongation (Yankulow et 
al. , 1996). During elongation TFIIH's association with pol II is less stable, but the ability 
of activators to stimulate elongation may bc associated with their TFIIH affinity (Yankulow 
et al. , 1994), During elongation CTD phosphatase acts exclusively on elongating pol II 
(Chambers et al. , 1995), so TFIIH kinase activity may be necessary to counteract this. 
It has been established that transcription and DNA repair are coupled mechanistically. 
So, not surprisingly, TFIIH has an additional function in DNA excision repair. Five ol 
TFIIH's nine subunits have both transcription and DNA repair functions coupling the two 
processes (Dombroski et al. , 1992; Drapkin et al. , 1994; Hutnbert et. al. , 1994; Schaeffer ct 
al. , 1994; Schaeffcr et al. , 1993). 
Initiation and Elongation 
After a closed transcription complex has assembled at the TATA element, the next step 
ol' initiation involves forming an open transcription complex. The formation of an open 
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complex occurs during promoter melting, the process of partially unwinding the DNA 
around the start site to provide access to pol II. The initial melting ranges from — 9 to +I 
(Jiang and Gralla, 1995; Kuhn et al. , 1993). One of the ATP-dependent helicases of 
TFIIH may be responsible for the initial melting, which requires hydrolysis of the P-y 
phosphoanhydride bond of ATP (or dATP). The open complex, less stable than an closed 
complex, is stabilized by the formation of thc first phosophodiester bonds. The formation 
of these ftrst phosphodiester bonds, which requires ATP, allows the expansion of thc 
melted region of DNA to +8 (Holstcge et al. , 1996; Holstege et al. , 1997), also ATP 
dependent (Wang ct al. , 1992a). After formation of three phosphodiester bonds in 
adenovirus major late promoter (AdML) promoter, the open complex is considered stable 
and no longer ATP dependent (Holstege et al. , 1997). The ATP-activated complex can 
undergo abortive RNA synthesis until pol II has cleared the promoter and becomes an 
elongation complex. 
Once pol II has moved past the first 11 to 16 base pairs, promoter clearance has 
occurred (Goodrich and Tjian, 1994; Dvir et al. , 1997; Holstege et al. , 1997). In the case 
of the AdML promoter, clearance occurs upon addttion of the eleventh nucleotide in the 
transcript. TFIIE and TFIIH have been shown to bc tmportant for promoter clearance in 
initiation and full length transcription assays (Goodrich and Tjian, 1994). Preinttiation 
polymerases lack phosphorylation (Lu et al. , 1991; Laybourn and Dahmus, 1989), but 
once hanscription has begun, the CTD repeats are phosphorylatcd. Phosphorylation of thc 
CTD requires ATP possibly utilized by the kinase activity of the cdk7 subunit or helicase 
activity of the ERCC3 subunit of TFIIH (Jiang et al. , 1996; Dvir et al. , 1997). The 
phosphotylation of the CTD, although not required for transcription, may help stalled 
transcription complexes continue (Jiang et al. , 1996; O' Brien et al. , 1994). In addition, the 
hyperphosphorylated CTD may play a role in promoter clearance, the shift from an 
mitiation complex to an elongation complex, The phosphorylation of the CTD may allow 
the release of GTI's involved m transcriptton and make room for the association of factors 
involved in elongation. Experiments involving RNA chain terminator 3'-0'methyl-GTP or 
kinase inhibitor N-(2-[methylamtno]ethyl)-5-isoquinolinesulfonamide (H8) have shown 
complexes with a phosphor lated CTD elongate more efficiently (Lee and Greenleaf, 1997; 
Dvir et al. , 1997). 
Once pol II clears the promoter, the GTFs are released except TFIIF. TFIIF stimulates 
the rate of elongation. Additional elongation factors, such as TFIIS, associate with pol II. 
TFIIS helps alleviate stalled complexes by stimulating a pol II nuclcase activity that cleaves 
dinucleotides from the transcript allowing realignment of pol 11's active site with the 3' end 
of the transcript (Izban and Luse, 1992b; lzban and Luse, 1993; Bengal et al. , 1991; 
Cipres-Palacin and Kane, 1994). 
Adenovirus major late promoter 
The adenovirus major late (AdML) promoter serves as one of the two originally 
proposed model promoters in thts research along with mouse mammary tumor virus 
(MMTV), but now serves as the only model due to circumstances discussed later. 
Adenoviruses infect the respiratory and urinary tracts, eye, lymphocytes, and entcrocytes 
of mammals, birds, and amphibians. The virus is transmitted through direct contact, 
aerosols, or oral ingestion. Thc adenovirus contains a linear, double stranded DNA 
molecule of 40kbp. A human adenovirus known to cause sarcoma provided a model for 
viral oncogenesis. In the later stages of viral infection, the A&ML promoter drives late 
transcnption of the viral DNA encoding virion capsid proteins (Horowitz, 1990). 
The AdML promoter serves as the model promoter in in vitro studies of eukaryottc 
transcription with pol II (Horowitz, 1990). AdML is one of the strongest basal promoters 
known. In contrast, thc MMTV promoter is very weak. The AdML promoter has three 
sequence elements (Fig. 2) that serve as binding sites during transcription. The first 
element, an upstream stimulatory factor (USF) binding site, is located at M4 to — 52. 
Downstream of the USF binding site at — 33 to — 22 exists a TATA box, and finally at — 1 to 
+5, an Inr element (Berk, 1986; Smale and Baltimore, 1989). 
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AdML promoter 
-60 
-)0 
U SF TATA Inr 
Fig. 2. The AdML promoter has a USF binding site, a TATA box, and an initiator 
element (Inr). 
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USF, a hetcrodimer of 43 kDa and 44 kDa subunits, serves as an activator during 
transcription. Under reducing conditions affecting key cysteinc residues, each subunit 
bound as a homodimer can activate transcription (Pognonec et al. , 1992; Pognonec et al. , 
1991). In vitro activation occurs via two different domains located in residues 15 to 59 and 
93 to 156 (Kirschbaum et al. , 1992). However, USF activation in highly purified systems 
is significantly reduced, but can bc restored with the presence of TAFs (Kokubo, 1993). It 
has been shown that mutations of the USF site in the AdML promoter decrease the stability 
of ATP-activated transcription complexes (Kopytck, 1997). 
The TATA element serves as a binding site for the TBP subunit of TFIID. The lnr 
element assists the TATA box in specific transcriptional initiation and may regulate the 
strength of the promoter (O'Shca-Greenfield and Srnalc, 1992). Many different proteins 
can bind the lnr in AdML, such as USF, TFII-I (120 kDa), and cap binding factor (Du et 
al. , 1993; Garfinkel et. al. , 1990; Roy et al. , 1991). TFII-I inay also bind in association 
with other proteins at the USF site (Roy ct al. , 1991). 
Objectives 
Determine the effect ol thc activator USF on AdML promoter clearance. This involves: 
1) designing wild type and USF deleted AdML promoter-containing templates with G-free 
cassettes at +12 to +36 of the template (promoter clearance occurs after +11), 2) perform 
controls to determine if promoter clearance assay will work, and 3) perform time courses 
for promoter clearance assay. 
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MATERIALS AND METHODS 
All DNA restriction and modification enzymes came from Promega or Gibco BRL. The 
ADPROCLR promoter came froin Life Technologies. 
Plasmids 
Two G-free templates, pwtptCI and pAUSFPrCl, containing AdML sequences were 
constructed as follows. Plasmid pBMLA-12 (ADVS wild type), a G-free template, 
contains AdML sequences from — 65 to +10 and specifies a transcript of 144 nt . Plasmid 
pUSFMLA (lacks USF sile), a G-free template derived from pBMLA-12, contains AdML 
promoter sequences from — 41 to +10, and produces a 144 nt transcripi. . Plasmids pwiPrC1 
and pAUSFPrC1 were derived from pBMLA-12 and pUSFMLA respectively through PCR 
amplification of the promoter and G-I'ree cassette. Thc first primer, a reverse sequencing 
primer (5*-AACAGCTATGACCATG-3') hybridized upstream of the promoter in a region 
of the vecior plasmid possessing a Hind III site. Thc second primer (ADPROCLR) 
contains a 3' overhang with a Kpn I restriciion site 
(5'-CGGGGTACCGTATAGATGGAGGAAGGGTATTGGGCGGAAGAGAGT-3') that 
hybridizes within the G-I'rec cassette, with the exception of intended mismatchcs, at 
sequences +1 to +36, resulting in the generation of a G-free cassette from +12 to +36. The 
PCR products were isolated from a 4% aciylamide gel, ethanol precipitated, resuspended in 
50 Itl of distilled water and Multicore buffer, and digested with both Hind III and Kpn I. 
After running part of the digested product on a 4% acrylamide gel to check for the presence 
of a band of correct molecular weight; the product was phenol extracted, ethanol 
precipitated, and resuspended in 10 Itl of distilled water. Also, pUC 19 was digested with 
Hind III and Kpn I and checked for linearization on a 1% low-melt agarose gel. All of the 
insert was added to -100 qg of large vector fragment and ligated at 37'C using T4 ligase 
for 60 minutes. Then the plasmids were transformed into HB101 compeient cells. The 
templates werc sequenced io assure they were as intended using thc dideoxy method. After 
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determining the sequence was correct, large scale plasmid purification (using alkali lysis) 
was used to obtain templates for transcription reactions. 
In vitro transcription reactions 
Nuclear extract (45 Itg of protein) was incubated on ice for 15 minutes in TM0. 1 buffer 
(50 mM Ttds-HCl (pH 7. 9 at room temperature), I mM EDTA, 12. 5 mM MgClz, 20% 
glycerol, and 100 mM KC1) and 5 mM DTT. The DTT prevents loss of the nuclear 
extract's activity during storage at -80'C. Tr'anscription complexes were assembled in 
batch with about I Itg of template per reaction. Assembly occurred for 60 minutes at 
30'C. Nucleotides and DEPC-treated water were added to make the final volume of the 
reactions 35 ItL. The final concentrations for the reagents were 300 ltM ATP, 300 ItM 
UTP, 1 ltM CTP, I ItM GTP (when used), 0 AM — I mM 3'-0-methyl GTP (Pharmacia), 
and 50 ltM (10 pCi) [ct- P]CTP (New England Nuclear). RNA synthesis occurred for 30 
minutes at. 30'C. The reactions were stopped with 90 mM EDTA (removes Mg ) and 
treated with 0. 2 ltl of RNase Tl (BRL) at 37'C for 15 minutes. Then, thc reaction was 
treated with 2 ItL of proteinase K and 350 ltl of stop buffer solution. Stop buffer consists 
of 50 mM Tris-HCI (pH 7. 5), 1% SDS, SmM EDTA, and 25 iLg/ml tRNA (Sigtna). The 
reactions were extracted with 385 ItL of chloropane. Chloropane is a 1:1 mixture ol' 
phenol and chloroform with a salt solution consisting of 100 mM Tris-HCI (pH7. 5), 
10mM sodium acetate, 100 mM NaCI, and I mM EDTA. Finally the reactions were ethanol 
precipitated and resuspended in transcription dye (0. 1% xylene cyanol, 0. 1% bromophcnol 
blue). The RNA products were examined on 20% polyacrylamide gels in thc presence of 
8M urea. 
Synthesis of RNA markers and recovery control 
RNA markers and recovery control were produced using the SP6 prornotcr of pGEM 
(Promega). The markers were synthesized in separate reactions using pGEM lincarized 
with Hind 111, Hinc II, Sal I, Xba I, and Bam HI, resulting in marker sizes ol' l l, 24, 26, 
32, and 38-mcr respectively. In the reaction 2 ltg of linear template was added to 
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transcription buffer containing 40 mM Tris-HC1 (pH 7. 5), 6 mM MgCls, 2 mM 
spermidine, 10 mM NaC1, and 10 rrdvf DTT supplemented with 2. 5 mM ATP, GTP, UTP, 
0. 25 mM CTP, 1 U/ml RNasin (Promega), and 10 lrCt [ct-' P]CTP. To synthesize the 
markers 20 U of SP6 RNA polymerase (BRL/Gibco) was used at 37'C for 60 minutes. 
Reactions were terminated wtth the addition of 350 itl of stop solution, chloropanc 
extracted, ethanol precipitated, and resuspended in 100 )tl of DEPC-treated water. The 11- 
mer, 24-mer, and 32-mcr were selected as th'e best markers upon analysis. The 11-mer 
contained an additional thrcc bands, which probably difler by one base pair. 
The recovery control was performed in much the same way with the following 
exceptions. The pGEM was linearized with Pvu Il, which cleaves 98 base pairs 
downstream from the transcription start site. SP6 RNA polymerase reactions were 
performed using 1 ltg of template and 10 U of the SP6 polymerase. Dilutions of the final 
product were made to determine what amount is best to serve as a recovery control. 
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RESULTS 
Controls for promoter clearance assay 
In theory thc promoter clearance assay ts very simple (Fig. 3). At the time, t, when 3'- 
0-methyl GTP is added if pol Il has not cleared the promoter (transcribed beyond+11) the 
chain terminator will be incorporated at+11 terminating transcription resulting in the 
present of an 11-mer. If at time t pol II has cleared the promoter (transcribed beyond +11), 
pol II will be able to complete transcription through the entire G-free cassette. Upon 
treatment with Tl a 26-mcr will be generated by all transcription complexes that had cleared 
the promoter at the time of 3'-0-methyl GTP addition. Based on this premise thc 
concentration of the 26-mer at thc various time points, t, can be used to determine the rate 
of promoter clearance. After determining the rates for the plasmids, pwtPrC1 and 
pAUSFPrCI, it can bc determined if USF alyects the rate of promoter clearance. 
Cun ently the controls for the promoter clearance assay are in progress. The controls 
answer many questions necessary to prove this assay will work since it has never been 
attempted before. First, does the template work. Second, what concentration of 3'-0- 
methyl GTP terminates transcription in a 100% effective way. Third, what background 
interference will be observed from the vector since it does contain many G-free regions, 
To answer these questions a series of in vitro transcription reactions were conducted with 
the method dtscussed in the MATERIALS AND METHODS. 
The reactions were perfortned on pUC 18 (which is the same as pUC 19 but in an 
opposite orientation) and pwtPrC1. The stopped reactions were all treated v, ith RNasc Tl. 
One of the reactions was lacking GTP thus it should result in an I 1-mer while another 
reactton lacked 3'-0-methyl GTP that should result in a 26-tner. The results were as 
follows. In pwtPrCI reactions a promoter dependent band was observed (not observed in 
pUC 18) that decreased with increased concentrations of 3'-0-tnethyl GTP (I'ig. 4, lanes 
10-14). However at. thc time there was a lack of markers to distinguish the stzc of the 
band, although the band is probably the 26-mer, Any band the size of an 11-mer was 
Gfree cassette NO RNA 
+ 1 
Gfree cassette NO PROMOTER CLEARANCE, CAN'T CHASE, NO RNA 
free cassette PROMOTER CLEARANCE, 
CAN CHASE, RNA 
+ 1 
Gfree cassette PROMOTER CLEARANCE, RNA 
Fig. 3. Outcomes of promoter clearance assay. 
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1 2 3 4 5 6 7 8 9 I011121314 
Fig. 4. Control for promoter clearance assay using both 
pwtPrCI and pUC 18, treated with RNase T1. Lanes 1-7 
and 8-14 used pwtPrCI and PUC 18. Lanes 1, 2, 8, and 9 
lacked GTP, but had 500 pM (lanes 1 and 8) and 1000 ttM 
(lanes 2 and 9), Reactons in lanes 3-7 and 10-14 each 
GTP (1@M) and increasing [3'-O-Me-GTP], 0 pM-1000ttM. 
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impossible to distinguish. The amount of bands observed in the pUC decreased 
substantially with increased concentrations of 3'-0-methyl GTP. 
The second attempt at the controls was performed in the same manner with the following 
modifications. The CTP concentration in the reactions was reduced to 0. 4 ItM. In 
addition, a series of reactions were performed with pwtPiCI that. lacked Tl treatment. In 
pwtPrCI reactions lacking Tl if the 3'-0-methyl GTP concentration is high enough only an 
11-mer should be observed. In the reaction tliai. lacks 3'-0-methyl GTP there should be no 
distinguishable bands due to many different bands of various sizes. In the reactions 
lacking GTP only 11-mers should be distinguishable. The results of thc reactions 
involving TI treatment were the same as in the first attempt. However it was observed in 
the reactions lacking TI treatment at the higher concentrations of 3'-0-methyl GTP a 37- 
mer was observed (Fig. 5, lanes I, 2, 6, and 7) meaning the reactions did not terminate at 
+11 as expected, but terminated at +37. So termination was more efficient at +37 then 
+11. A possible explanation for the read through at +11 was misincorporation of an NTP 
other than GTP. At +38 of the template strand another location for GTP or 3'-0-methyl 
GTP to be incorporated exist which possibly lead to inore efficient termination at the end of 
the G-free cassette. 
The third al. tempt at the controls was quite different from the others. Reactions were 
performed on both pUC 18 and pwtPrCI with and without Tl treatment. The CTP 
concentration in the reactions was O. S Iridal. The concentration in the reactions of both ATP 
and UTP were reduced to 100 ItM (to reduce thc chance of mtsincotporation) and GTP 
reduced to 0. 5 ItM. A concentration of 2 mM 3'-0-methyl GTP was used in reactions 
except for those lacking it. The actual elongating period of thc transcription reactions was 
reduced to S minutes to give thc polymerase less time to read through the G-free cassette. 
Three reaction conditions existed: I) no GTP, 3'-0-methyl GTP present; 2) GTP, no 3'-0- 
methyl GTP; and 3) both GTP and 3'-0-methyl GTP present. In this experiment markers 
were employed of the following size I l-mcr, 24-mer, and 32-mer. This experiment was 
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1 2345 67 
Fig. 5. Control for promoter clearance assay using 
pwtPrCI not treated with RNAse T1. Reactions in lanes 1 
and 2 lack GTP, but have 3'-O'Me-GTP at 500 trM and 
1000 p, M respectively. Reactions in lanes 3-7 have GTP (1 
trM) and increasing [3'-O'Me'GTPj, 0 frM-1000 pM. 
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not nearly as clean as the other experiments, but some observations were possible. First, a 
37-mer was present in a Tl treated reaction involving pwtPrC1 that had GTP, but did not 
have 3'-0-methyl GTP (Fig. 6, lane 5). This suppotts a misincorporation, because a 37- 
mer should not be present. Second, a 37-mer was present in a reaction involving pwtPrC1, 
not treated with Tl, that lacked GTP, but had 3'-0-methyl GTP supporting that termination 
at +11 is not efficient or misincorporation (Fig. 6, lane 1). 
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Fig. 6. Control for promoter clearance assay using both 
pwtPrCI and pUC 18. Lanes 1-6 and 7-12 used pwtPrCI and 
pUC 18 respectively. Lane 13 has no plasmid, Lanes 4-6 and 
10-12 were treated with RNase T1. Lanes 1, 4, 7, and 10, 
reactions lacked GTP, but had 2 mM 3'-0-Me-GTP. Lanes 2, 5, 
8, and 11, reactions had 0. 5 p, M GTP, but lacked 3'-O-Me-GTP. 
Lanes 3, 6, 9, 12, and 13, reactions had 0. 5 pM and 2mM 3'-0- 
Me-GTP. Lanes 14 and 15 are the 32 and 24-mer RNA 
markers respectively. 
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DISCUSSION 
There are more control experiments to be performed in an attempt to show that the 
promoter clearance assay is feasible. However, thc early indications have shown possible 
misincorporation or a low efftciency at tetminating at +11 during the controls. In attempts 
to combat misincorporation thc concentration of the NTPs could bc reduced even more, but 
the difficulty of geuing transcription increases. If read-through at+11 still occurs after 
stretching the reactions condittons as much a's possible that probably indicates a low 
efficiency of termination at +11. Also, read-through at +11 may not bc promoter or pol Il 
dependent, which can be determined by using ct-amaniun in some reactions. As a result the 
templates will have to be redcsigned to bc able to incorporate another GTP or 3'-0-methyl 
GTP at +12. Of course this could possibly result in a doublet of a 26 and 25-mer. In 
hindsight this probably would have been a better design to begin with for the templates. 
Also, another option that may be considered as a further conuol is to design a TATA 
mutant. with the G-free cassette in the appropriate place to show that the presence of the 26- 
mer is promoter dependent. 
Controls so far have shown the presence of promoter specific transcripts distinguishable 
from thc background. In addition, 3'-0-methyl GTP at high concentrations terminates 
transcription almost completely. However, it is still not quite clear if it is efficient enough 
for t. he promoter clearance assay. 
Assuming the controls work proving that the promoter clearance assay is feasible. The 
next step will be running a time course using the promoter clearance assay for plasmids, 
pwtPrC1 and pAUSFPrCI. This differs from the previous transcription reactions because 
the 3'-0-methyl GTP is added at a ttme, t, after the transcription reaction began. The series 
of times chosen for the time courses will constitute a vety short period of time. It is highly 
likely that a stop-flow rnachine will be needed to conduct the reactions. The use of the 
stop-flow machine may change the amount of reactants needed. 
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If USF is found to have an effect on the rate of promoter clearance, there are plans to 
study it further. For example, templates with heteroduplexes at the start site will be used to 
help discern the transctfption step the activator, USF, affects. Also, if these experiments 
work in determining the effect of activators on promoter clearance the promoter clearance 
assay can be applicable to determine the effect different activators have on specific 
promoters concerning promoter clearance. 
As a side note many attempts over a six-month period were made to find a MMTV 
transcript. that would transctibe so experiments, including the promoter clearance assay, 
could be conducted. However despite these efforts a working template was never found. 
Possibly the frozen stock of the plasmids was contaminaied with something such as 
RNase. Another option is the nuclear extract was not as good as past nuclear extracts 
making it difficult to use MMTV promoter-containing templates since it is a very weak 
promoter. MMTV possesses binding sites for both repressors and activators. MMTV as a 
weak promoter would have provided a nice contrasl to AdML in the experiments. 
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